Skip to main content
. Author manuscript; available in PMC: 2020 Aug 17.
Published in final edited form as: Clin Infect Dis. 2020 Aug 14;71(4):1010–1016. doi: 10.1093/cid/ciz914

Table 5.

QTc Abnormalities and Medical Outcomes

Patient No. QTc Baseline QTc Peak Concurrent QTc-Prolonging Drugs Medical Response Finished Course of Bedaquiline?
  1 384 469 CFZ None Yes
  3 439 507 CFZ, LFX Bedaquiline discontinued No
  4 411 475 CFZ, LFX None Yes
11 442 536 MFX None because QTc was 432 the day after the peak value Yes
12 400 610 LFX K+ = 2.2; bedaquiline stopped and restarted two weeks after K+ replenished Yes
14 483 (3 months after bedaquiline started) 546 (1 day after bedaquiline was stopped) MFX, CFZ, Effexor, Zofran MFX and CFZ stopped sequentially until QTc decreased Yes

Abbreviations: CFZ, clofazimine; LFX, levofloxacin; K+, potassium; MFX, moxifloxacin; QTc, corrected QT interval.